DGAT2 and breast carcinoma: More surprisingly, both DGAT2 and CCDC69 have CNV mutations in Her2-positive breast cancer; DGAT2 expression increases as copy number increases, whereas an increase or increase in CCDC69 copy number results in a decrease in its expression.